Three banned products by ANMAT

November 28, 2018

The official communication came from a new provision made public by the edition of the Official Journal.

The National Administration of Drugs, Food and Medical Technology (ANMAT) prohibited the distribution, marketing and use of three medical products through the provision 2021/2018 of the Official Bulletin of this November 28.

It's about the products "Arrope of tuna";"Honey of Caña"And"Cranberry berrys ", all brand El Pbad, regional handicraft product, with the numbers RNPA 22035755 and RNE 22002034, Route 204 – Bobadal – Santiago del Estero, which" do not comply with the regulations in force on food ".

The text of ANMAT states that "the products contravene Article 3 of Law 18284, Article 3 of Annex II of Decree 2126/71 and Articles 6a, 13 and 155 of the CAA, because they do not have authorizations and product, be falsely labeled, making it illegal "

It is also stated that "because these are products that can not be reliably and clearly identified as being produced, processed and / or divided into a specific establishment, they can not be produced either domestically, marketed or marketed. sold on its territory. " In accordance with the provisions of Article 9 of Law No. 18284 and the latter, INAL's Legislation and Regulations Department recommends that the above-mentioned products be banned throughout the national territory.

"The procedure described in the control and control functions that corresponds to the exercise of the National Administration of Medicine, Food and Medical Technology (ANMAT), paying attention to a responsibility in health care that adapts to the population "also said.

On Tuesday, the administration also issued other bans. It is the "Volumat volumetric infusion pump, model Agilia", which has the following serial number: 22029379, 22029380, 22029395, 22029635, 22029646, 22029648, 22029751, 22029767, 22029803 and 2205106.

The decision was taken after the signature "FRESENIUS KABI S.A", manufacturer and importer of medical products authorized by this national administration by the ANMAT decree n ° 7854/14, reports the loss of 10 units.

ANMAT Prohibits the Marketing of a Medical Product